WTX-124

N/A

Report date: 2025/10/21 14:45:46

Base Information

Drug NameWTX-124
Drug Alias NameWTX-124
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterleukin-12 replacements
TargetsInterleukin-12
Therapy Area/IndicationsSolid tumoursSkin Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesWerewolf Therapeutics Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumoursSkin Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A